No association of ALOX5AP polymorphisms with risk of MRI-defined brain infarcts

Neurobiology of Aging

Volumn 33, Issue 3, 2012, Pages 629.e1-629.e3

  Barral, Sandra ^a,b   Fernández Cadenas, Israel ^c   Bis, Joshua C ^d,e   Montaner, Joan ^c   Ikram, Arfan M ^f,g   Launer, Lenore J ^h   Fornage, Myriam ⁱ   Schmidt, Helena ^j   Brickman, Adam M ^a,b   Seshadri, Sudha ^k   Mayeux, Richard ^a,b  

^a Department of Epidemiology   (United States)

^b New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g Netherlands Consortium for Healthy Ageing   (Netherlands)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

ⁱ UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^j MEDICAL UNIVERSITY OF GRAZ   (Austria)

^k BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

ALOX5AP; MRI defined brain infarcts

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN;

ALOX5AP GENE; ARTICLE; BRAIN INFARCTION; COHORT ANALYSIS; CONTROLLED STUDY; EUROPE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84855769006     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.10.010     Document Type: Article

References (8)

1. Brickman A.M., Schupf N., Manly J.J., Luchsinger J.A., Andrews H., Tang M.X., Reitz C., Small S.A., Mayeux R., DeCarli C., Brown T.R. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol 2008, 65:1053-1061.
2. Debette S., Bis J.C., Fornage M., Schmidt H., Ikram M.A., Sigurdsson S., Heiss G., Struchalin M., Smith A.V., van der Lugt A., DeCarli C., Lumley T., Knopman D.S., Enzinger C., Eiriksdottir G., Koudstaal P.J., DeStefano A.L., Psaty B.M., Dufouil C., Catellier D.J., Fazekas F., Aspelund T., Aulchenko Y.S., Beiser A., Rotter J.I., Tzourio C., Shibata D.K., Tscherner M., Harris T.B., Rivadeneira F., Atwood L.D., Rice K., Gottesman R.F., van Buchem M.A., Uitterlinden A.G., Kelly-Hayes M., Cushman M., Zhu Y., Boerwinkle E., Gudnason V., Hofman A., Romero J.R., Lopez O., van Duijn C.M., Au R., Heckbert S.R., Wolf P.A., Mosley T.H., Seshadri S., Breteler M.M., Schmidt R., Launer L.J., Longstreth W.T. Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke 2010, 41:210-217.
3. Gauderman W.J. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002, 21:35-50.
4. Helgadottir A., Manolescu A., Thorleifsson G., Gretarsdottir S., Jonsdottir H., Thorsteinsdottir U., Samani N.J., Gudmundsson G., Grant S.F., Thorgeirsson G., Sveinbjornsdottir S., Valdimarsson E.M., Matthiasson S.E., Johannsson H., Gudmundsdottir O., Gurney M.E., Sainz J., Thorhallsdottir M., Andresdottir M., Frigge M.L., Topol E.J., Kong A., Gudnason V., Hakonarson H., Gulcher J.R., Stefansson K. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004, 36:233-239.
5. Purcell S., Cherny S.S., Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
6. Quarta G., Stanzione R., Evangelista A., Zanda B., Di Angelantonio E., Marchitti S., Di Castro S., Di Vavo M., Volpe M., Rubattu S. Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in Sardinians. Eur J Hum Genet 2009, 17:1448-1453.
7. Reitz C., Schupf N., Luchsinger J.A., Brickman A.M., Manly J.J., Andrews H., Tang M.X., DeCarli C., Brown T.R., Mayeux R. Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol 2009, 66:834-840.
8. Zee R.Y., Cheng S., Hegener H.H., Erlich H.A., Ridker P.M. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach. Stroke 2006, 37:2007-2011.